Chemical compounds

Details Chemical compounds Chemical compounds

2001-05-30

2008-03-25

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S326000, C514S331000, C546S193000, C546S212000, C546S229000

Reexamination Certificate

active

07348341

ABSTRACT:
The invention concerns compounds of formula (I), and their use in therapy, particularly in the modulation of CCR3 activity.

REFERENCES:
patent: 4335127 (1982-06-01), Vandenberk et al.
patent: 4853393 (1989-08-01), Zimmermann
patent: 5143923 (1992-09-01), Hrib et al.
patent: 5210086 (1993-05-01), George et al.
patent: 6140344 (2000-10-01), Gong et al.
patent: 6518286 (2003-02-01), Baxter et al.
patent: 6946478 (2005-09-01), Baxter et al.
patent: 2003/0050309 (2003-03-01), Aquila et al.
patent: 0124476 (1984-11-01), None
patent: 0184258 (1986-06-01), None
patent: 0288563 (1988-11-01), None
patent: 0 429 341 (1991-05-01), None
patent: 0 429 341 (1991-05-01), None
patent: 0515240 (1992-11-01), None
patent: 0661266 (1995-07-01), None
patent: 0903349 (1999-03-01), None
patent: 2 675 801 (1992-10-01), None
patent: 2724382 (1996-03-01), None
patent: 1243991 (1971-08-01), None
patent: 09040646 (1997-02-01), None
patent: 09077742 (1997-03-01), None
patent: 03264579 (1999-11-01), None
patent: WO96/14317 (1996-05-01), None
patent: WO 96/29330 (1996-09-01), None
patent: WO 97/10207 (1997-03-01), None
patent: WO 97/42956 (1997-11-01), None
patent: WO 97/49680 (1997-12-01), None
patent: WO99/04794 (1999-02-01), None
patent: WO 99/37617 (1999-07-01), None
patent: WO 99/37619 (1999-07-01), None
patent: WO 99/38514 (1999-08-01), None
patent: WO 00/29377 (2000-05-01), None
patent: WO 00/35877 (2000-06-01), None
patent: WO 00/58305 (2000-10-01), None
patent: WO 01/14333 (2001-03-01), None
patent: WO02/20484 (2002-03-01), None
patent: WO 02/30899 (2002-04-01), None
patent: WO 03/018556 (2003-03-01), None
patent: WO03/18556 (2003-03-01), None
patent: WO 03/18566 (2003-03-01), None
Bundgaard “Design of prodrugs” p. 1 (1986).
Cohen et al. “Cytokine function . . . ” CA 125:3527 (1996).
King “Medicinal chemistry: principle and practice” p. 206-209 (1994).
Rubini et al. “Synthesis of isosteric methylen-oxy . . . ” Tetrahedron v. 42, p. 6039-45 (1986).
Ian T. Forbes et al., “(R)-3, N-Dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl)propyl]benzenesulfonamide: The First Selective 5-HT7Receptor Antagonist” 41 Journal of Medicinal Chemistry 5, 655-657 (1998).
Jean-Luc Malleron et al., “New Indole Derivatives as Potent and Selective Serotonin Uptake Inhibitors” 36 J. Med. Chem. 1194-1202 (1993).
Maria López-Rodriguez et al., “First Pharmacophoric Hypothesis for 5-HT Antagonism” 10 Bioorganic & Medicinal Chemistry Letters 1097-1100 (2000).
Acs et al., “Preparation of N-(4-piperidinylbutyl)carboxamides as D3 receptor agonists for treatmant of CNS and ophthalmic disorders”, CAPLUS, Accession No. 2003:282395; Document No. 138:287532, 2003, 2 pages.
Baxter, “Preparation of piperidinyl compounds as modulators of chemokine receptor activity”, CAPLUS, Accession No. 2000:707161; Document No. 133:266738, 2000, 7 pages.
CAS printout for Kikuchi et al.,Chem. Abs.128:22926 (JP 09291090).
CAS printout for Takahashi et al.,Chem Abs.128:294706 (JP 10077271).
CAS printout for Vandenberk et al.,Chem Abs.97:856 (1982).
Emonds-Alt et al., “Preparation of N-(aminoalkyl)piperidines, their enantiomers, and pharmaceutical compositions as neurokinin receptor antagonists”, CAPLUS Accession No. 1993:408684; Document No. 119:8684.
Herndon et al., “Ketanserin Analogues: Structure-Affinity Relationships for 5-HT2and 5-HTICSerotonin Receptor Binding”,J. Med. Chem.35:4903-4910 (1992).
Hrib et al., “Benzisoxazole-and Benzisothiazole-3-carboxamides as Potential Atypical Antipsychotic Agents”,J. Med. Chem.37:2308-2314 (1994).
Jansson et al., “Synthesis of3H and14C Ketanserin”,Journal of labelled Components and RadiopharmaceuticalsXXV(7):783-792 (1988).
Nakazato et al.,Chem. Abs.126:8111 (WO 9629330).
STN International, File CAPLUS, accession No. 1996:113480, Document No. 124:220549, Kharkovskij Farmatsevticheskij Institut: “Piperdylamide of 3,5-dibromo-4-aminobenzene-sulfonylaminosuccinic acid which produces neuroptic and diuretic effects”, & SU, A1, 1824396, Jun. 30, 1993, 2 pages.
CAS ONLINE on STN, Chem. Abstr., Accession No. 1980:586265, Carissimi et al. Farmaco, edizion Scientifica (1980), 35(6), 504-26, abstract only.

Affiliated with

Also associated with

Rating

Chemical compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemical compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemical compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3980222